The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 25, 2024

Filed:

Oct. 05, 2017
Applicant:

Arizona Board of Regents on Behalf of the University of Arizona, Tucson, AZ (US);

Inventor:

Klearchos K. Papas, Tucson, AZ (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61L 27/54 (2006.01); A61F 2/02 (2006.01); A61K 35/12 (2015.01); A61K 35/13 (2015.01); A61K 38/19 (2006.01); A61K 39/39 (2006.01); A61L 27/36 (2006.01); A61P 35/00 (2006.01); A61K 9/00 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61L 27/54 (2013.01); A61F 2/022 (2013.01); A61K 35/12 (2013.01); A61K 35/13 (2013.01); A61K 38/19 (2013.01); A61K 39/39 (2013.01); A61L 27/3683 (2013.01); A61P 35/00 (2018.01); A61K 9/0024 (2013.01); A61K 2039/515 (2013.01);
Abstract

Methods, systems, and devices for enhancing cancer immunotherapy featuring co-transplantation of encapsulated xenogeneic cells with separately encapsulated autologous or allogeneic cells, e.g., autologous or allogeneic tumor cells. For example, both a first cellular transplantation device housing a patient's own tumor cells and a second cellular transplantation device housing xenogeneic cells may be implanted into a patient. The presence of the xenogeneic cells elicits an enhanced immune response, e.g., the xenogeneic cells will draw in a large number of immune cells. Shed tumor antigens from the first cellular transplantation may then be taken up by the immune cells that were drawn to the xenogeneic cells. This will generate an anti-tumor immune response that is amplified relative to a response elicited by the encapsulated tumor cells alone.


Find Patent Forward Citations

Loading…